Company news
Chengdu Olymvax Biopharmaceuticals Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Release of Pledge of Some Shares Held by Shareholders with Over 5% Shares
May 26, 2025
Indicative Announcement on Postponing Term Change of Board of Directors and Board of Supervisors and Expiration of Term of Independent Director
May 16, 2025
Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market 2024 and the Q1 2025 Performance Briefing
April 25, 2025
Announcement on Resolutions of 2024 Annual General Meeting
April 18, 2025
Announcement on Convening 2024 Annual Performance and Cash Dividend Briefing
March 31, 2025
Announcement on Provision for Asset Impairment in 2024
March 28, 2025
Announcement on Change of Sponsor Institution and Sponsor Representative
March 24, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Voluntary Disclosure of Initiation of Phase I Clinical Trial for Trivalent and Tetravalent Influenza Vaccine (Split Virus, MDCK Cells) and Completion of First Subject Enrollment
February 21, 2025
Announcement on Obtaining Government Subsidy
January 22, 2025